A detailed history of Northwestern Mutual Investment Management Company, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Northwestern Mutual Investment Management Company, LLC holds 27,580 shares of ARWR stock, worth $536,431. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,580
Previous 27,720 0.51%
Holding current value
$536,431
Previous $720,000 25.97%
% of portfolio
0.01%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$19.36 - $29.54 $2,710 - $4,135
-140 Reduced 0.51%
27,580 $533,000
Q2 2024

Aug 15, 2024

BUY
$21.87 - $28.24 $1,858 - $2,400
85 Added 0.31%
27,720 $720,000
Q1 2024

May 15, 2024

BUY
$27.21 - $39.48 $103,071 - $149,550
3,788 Added 15.88%
27,635 $790,000
Q4 2023

Feb 13, 2024

BUY
$21.2 - $31.03 $1,568 - $2,296
74 Added 0.31%
23,847 $729,000
Q3 2023

Nov 14, 2023

BUY
$26.2 - $36.08 $419 - $577
16 Added 0.07%
23,773 $638,000
Q2 2023

Aug 14, 2023

SELL
$25.16 - $41.38 $6,843 - $11,255
-272 Reduced 1.13%
23,757 $847,000
Q1 2023

May 15, 2023

BUY
$23.68 - $38.51 $337,037 - $548,112
14,233 Added 145.29%
24,029 $610,000
Q4 2022

Feb 21, 2023

SELL
$28.0 - $40.56 $153,748 - $222,714
-5,491 Reduced 35.92%
9,796 $397,000
Q3 2022

Nov 14, 2022

SELL
$29.63 - $48.31 $71,437 - $116,475
-2,411 Reduced 13.62%
15,287 $505,000
Q2 2022

Aug 04, 2022

BUY
$27.79 - $50.61 $5,057 - $9,211
182 Added 1.04%
17,698 $623,000
Q1 2022

May 09, 2022

BUY
$39.62 - $69.97 $9,231 - $16,303
233 Added 1.35%
17,516 $806,000
Q4 2021

Feb 03, 2022

BUY
$58.09 - $82.51 $3,485 - $4,950
60 Added 0.35%
17,283 $1.15 Million
Q3 2021

Nov 15, 2021

SELL
$58.38 - $84.96 $6,538 - $9,515
-112 Reduced 0.65%
17,223 $1.08 Million
Q2 2021

Aug 13, 2021

BUY
$62.15 - $90.32 $1,367 - $1,987
22 Added 0.13%
17,335 $1.44 Million
Q1 2021

May 14, 2021

SELL
$61.35 - $90.47 $1.11 Million - $1.63 Million
-18,019 Reduced 51.0%
17,313 $1.15 Million
Q4 2020

Feb 12, 2021

SELL
$43.82 - $85.37 $3,505 - $6,829
-80 Reduced 0.23%
35,332 $2.71 Million
Q2 2020

Aug 14, 2020

BUY
$26.12 - $43.27 $16,377 - $27,130
627 Added 1.8%
35,412 $1.53 Million
Q1 2020

May 08, 2020

BUY
$20.56 - $63.12 $127,328 - $390,902
6,193 Added 21.66%
34,785 $1 Million
Q4 2019

Feb 07, 2020

BUY
$28.14 - $73.01 $804,578 - $2.09 Million
28,592 New
28,592 $1.81 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.06B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Northwestern Mutual Investment Management Company, LLC Portfolio

Follow Northwestern Mutual Investment Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Investment Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Investment Management Company, LLC with notifications on news.